Based on these considerations, the main aim of our study was to use a more systematic assessment of ocular abnormalities and visual function with both a structured behavioral evaluation and a parent/carer-reported questionnaire (VISIOCHARGE) in a cohort of CS patients carrying CHD7 pathogenic variants. The gene discussed is CHD7; the disease is Cowden syndrome 1.